Skip to content

Clinical Effects of Absorbable and Non-absorbable Suture in Bronchial Sleeve Resection

Comparison of Clinical Effects of Absorbable and Non-absorbable Suture in Bronchial Sleeve Resection

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06344962
Enrollment
40
Registered
2024-04-03
Start date
2023-02-28
Completion date
2025-12-31
Last updated
2024-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suture, Complication

Keywords

Suture, Bronchial Sleeve Resection, Central Primary Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)

Brief summary

Bronchial sleeve resection is performed as an alternative to pneumonectomy for lung cancer patients with centrally located lesions and limited cardiopulmonary reserve. Intraoperative bronchial anastomosis is very complex and difficult, mainly due to the difficulty of suturing and knotting in limited space. There are currently few studies comparing the clinical effects of absorbable and non-absorbable suture in bronchial sleeve resection. So the investigator wants to conduct a prospective study, trying to figure out this problem.

Detailed description

Lung cancer has been one of the most serious life-threatening diseases of human society. It has the highest morbidity and mortality worldwide among all the malignant tumors. Although the treatment of lung cancer is increasingly diverse, surgical resection is still the mainstay. Pneumonectomy, as a surgical approach for central primary lung cancer, is very harmful to patients. Bronchial sleeve resection is performed as an alternative to pneumonectomy for lung cancer patients with centrally located lesions and limited cardiopulmonary reserve. Intraoperative bronchial anastomosis is very complex and difficult, mainly due to the difficulty of suturing and knotting in limited space. Both absorbable and non-absorbable suture are used for it. But there are currently few studies comparing the clinical effects of absorbable and non-absorbable suture in bronchial sleeve resection. So the investigator wants to conduct a prospective study, trying to figure out this problem. The investigator sets incidence rate of anastomotic complications as the primary endpoint. According to the calculation, a total of 40 patients will be enrolled (each group has 20 patients).

Interventions

3-0 V-Loc

3-0 Prolene

Sponsors

The Affiliated Hospital of Qingdao University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Age 18 to 75 years old. 2. The tumor is located in the opening of bronchus, or the edge of the tumor is less than 2 cm away from the opening of the bronchi, while the distance between the edge of the tumor and the carina is more than 1.5 cm. 3. Patients with pathological diagnosis of non-small cell lung cancer. 4. No distant metastasis in preoperative clinical evaluation. 5. Adequate cardiac function, pulmonary function, liver function and renal function for anesthesia and bronchial sleeve resection. 6. American Society of Anesthesiologists (ASA) score: Grade I-III. 7. Patients who can coordinate the treatment and research and sign the informed consent.

Exclusion criteria

1. Patients with a significant medical condition which is thought unlikely to tolerate the surgery or unsuitable for this study after the evaluation of the investigator. 2. Patients with psychiatric disease who are expected lack of compliance with the protocol.

Design outcomes

Primary

MeasureTime frameDescription
Incidence rate of anastomotic complications12 months after surgerysuch as anastomotic stenosis, anastomotic fistula and so on

Secondary

MeasureTime frameDescription
Time of bronchial anastomosisDuring surgeryFrom the first stitch to the last stitch
Number of stitchesDuring surgeryDuring bronchial anastomosis
5-year survival rate5 years after surgeryFollow up for 5 years

Countries

China

Contacts

Primary ContactZhe Wu, PhD
17863934867@163.com+86 17863934867

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026